Literature DB >> 18810454

Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Ahmed Ba-Ssalamah1, Martin Uffmann, Sanjai Saini, Nina Bastati, Christian Herold, Wolfgang Schima.   

Abstract

Screening of the liver for hepatic lesion detection and characterization is usually performed with either ultrasound or CT. However, both techniques are suboptimal for liver lesion characterization and magnetic resonance (MR) imaging has emerged as the preferred radiological investigation. In addition to unenhanced MR imaging techniques, contrast-enhanced MR imaging can demonstrate tissue-specific physiological information, thereby facilitating liver lesion characterization. Currently, the classes of contrast agents available for MR imaging of the liver include non-tissue-specific extracellular gadolinium chelates and tissue-specific hepatobiliary or reticuloendothelial agents. In this review, we describe the MR features of the more common focal hepatic lesions, as well as appropriate imaging protocols. A special emphasis is placed on the clinical use of non-specific and liver-specific contrast agents for differentiation of focal liver lesions. This may aid in the accurate diagnostic workup of patients in order to avoid invasive procedures, such as biopsy, for lesion characterization. A diagnostic strategy that considers the clinical situation is also presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810454     DOI: 10.1007/s00330-008-1172-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  68 in total

Review 1.  [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; F Streitparth; G Wieners; E Lopez-Häninnen
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 2.  Management of metastatic cancer to the liver.

Authors:  P H Sugarbaker; N Kemeny
Journal:  Adv Surg       Date:  1989

3.  Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI.

Authors:  Paolo Ricci; Andrea Laghi; Vito Cantisani; Pasquale Paolantonio; Sara Pacella; Elisa Pagliara; Federico Arduini; Valerio Pasqualini; Francesca Trippa; Marzia Filpo; Roberto Passariello
Journal:  AJR Am J Roentgenol       Date:  2005-03       Impact factor: 3.959

4.  Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.

Authors:  P Soyer; A C Dufresne; E Somveille; A Scherrer
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

5.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.

Authors:  Y Maetani; K Itoh; C Watanabe; T Shibata; F Ametani; H Yamabe; J Konishi
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

Review 6.  Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.

Authors:  J K McLarney; P T Rucker; G N Bender; Z D Goodman; N Kashitani; P R Ros
Journal:  Radiographics       Date:  1999 Mar-Apr       Impact factor: 5.333

7.  Cystic focal liver lesions in the adult: differential CT and MR imaging features.

Authors:  K J Mortelé; P R Ros
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

8.  Central scars in primary liver tumors: MR features, specificity, and pathologic correlation.

Authors:  E Rummeny; R Weissleder; S Sironi; D D Stark; C C Comptom; P F Hahn; S Saini; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

Review 9.  Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Authors:  Hale Ersoy; Frank J Rybicki
Journal:  J Magn Reson Imaging       Date:  2007-11       Impact factor: 4.813

Review 10.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

View more
  42 in total

1.  Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Katsuhiro Sano; Ali Muhi; Richard L Ehman; Tsutomu Araki
Journal:  Magn Reson Imaging       Date:  2011-09-19       Impact factor: 2.546

2.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

Review 3.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

4.  Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.

Authors:  Christian Grieser; Ingo G Steffen; Incken-Birthe Kramme; Hendrik Bläker; Ergin Kilic; Carmen Maria Perez Fernandez; Daniel Seehofer; Eckart Schott; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2014-06       Impact factor: 5.315

5.  Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.

Authors:  Jing Huang; Lihong Bu; Jin Xie; Kai Chen; Zhen Cheng; Xingguo Li; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2010-11-02       Impact factor: 15.881

Review 6.  [New developments in MRI of the liver].

Authors:  N Bastati-Huber; H Prosch; S Baroud; S Magnaldi; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.

Authors:  Yi-Xiang J Wang
Journal:  Quant Imaging Med Surg       Date:  2011-12

9.  Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.

Authors:  Peter Reimer; Rolf Vosshenrich
Journal:  Biologics       Date:  2010-08-09

10.  Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.

Authors:  Peter Bannas; Candice A Bookwalter; Tim Ziemlewicz; Utaroh Motosugi; Alejandro Munoz Del Rio; Theodora A Potretzke; Scott K Nagle; Scott B Reeder
Journal:  Eur Radiol       Date:  2016-04-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.